Oregon Public Employees Retirement Fund Purchases New Stake in Hims & Hers Health, Inc. (NYSE:HIMS)

Oregon Public Employees Retirement Fund purchased a new stake in Hims & Hers Health, Inc. (NYSE:HIMS) during the 4th quarter, Holdings Channel.com reports. The fund purchased 45,000 shares of the company’s stock, valued at approximately $1,088,000.

Several other hedge funds have also recently bought and sold shares of the business. Impact Investors Inc purchased a new position in Hims & Hers Health in the fourth quarter valued at approximately $1,260,000. Illinois Municipal Retirement Fund purchased a new position in Hims & Hers Health in the fourth quarter valued at approximately $2,608,000. Amalgamated Bank raised its holdings in Hims & Hers Health by 751.2% in the fourth quarter. Amalgamated Bank now owns 55,887 shares of the company’s stock valued at $1,351,000 after buying an additional 49,321 shares during the period. Bank of New York Mellon Corp raised its stake in shares of Hims & Hers Health by 128.7% during the fourth quarter. Bank of New York Mellon Corp now owns 1,244,953 shares of the company’s stock valued at $30,103,000 after purchasing an additional 700,500 shares during the period. Finally, South Dakota Investment Council purchased a new stake in shares of Hims & Hers Health during the fourth quarter valued at approximately $370,000. Hedge funds and other institutional investors own 63.52% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on HIMS shares. Piper Sandler lifted their price objective on shares of Hims & Hers Health from $24.00 to $35.00 and gave the company a “neutral” rating in a research note on Tuesday, February 25th. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Hims & Hers Health from $23.00 to $27.00 and gave the company a “hold” rating in a research note on Wednesday, November 6th. Bank of America lifted their price objective on shares of Hims & Hers Health from $18.00 to $21.00 and gave the company an “underperform” rating in a research note on Thursday, February 20th. Citigroup lifted their price objective on shares of Hims & Hers Health from $25.00 to $27.00 and gave the company a “sell” rating in a research note on Tuesday, February 25th. Finally, Truist Financial raised their price target on shares of Hims & Hers Health from $24.00 to $39.00 and gave the stock a “hold” rating in a research report on Wednesday. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $37.23.

Hims & Hers Health Stock Performance

NYSE:HIMS opened at $45.20 on Friday. The stock’s 50 day moving average price is $36.57 and its 200 day moving average price is $26.74. Hims & Hers Health, Inc. has a 52 week low of $11.20 and a 52 week high of $72.98. The company has a market capitalization of $10.04 billion, a P/E ratio of 102.72 and a beta of 1.35.

Hims & Hers Health (NYSE:HIMS) last released its quarterly earnings data on Monday, February 24th. The company reported $0.11 EPS for the quarter, topping analysts’ consensus estimates of $0.09 by $0.02. Hims & Hers Health had a return on equity of 10.97% and a net margin of 8.19%. The firm had revenue of $481.14 million for the quarter, compared to the consensus estimate of $494.56 million. As a group, sell-side analysts forecast that Hims & Hers Health, Inc. will post 0.29 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Hims & Hers Health news, insider Michael Chi sold 2,054 shares of the company’s stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $33.56, for a total transaction of $68,932.24. Following the completion of the sale, the insider now owns 184,947 shares of the company’s stock, valued at $6,206,821.32. This represents a 1.10 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Soleil Boughton sold 4,152 shares of the company’s stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $60.69, for a total value of $251,984.88. Following the sale, the insider now directly owns 157,345 shares of the company’s stock, valued at $9,549,268.05. The trade was a 2.57 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 1,097,578 shares of company stock worth $38,080,320. Insiders own 17.71% of the company’s stock.

About Hims & Hers Health

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.